Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014

Abstract

Objective To assess risk of cancer in patients with childhood onset inflammatory bowel disease in childhood and adulthood. Design Cohort study with matched general population reference individuals using multivariable Cox regression to estimate hazard ratios. Setting Swedish national patient register (both inpatient and non-primary outpatient care) 1964-2014. Participants Incident cases of childhood onset (<18 years) inflammatory bowel disease (n=9405: ulcerative colitis, n=4648; Crohn’s disease, n=3768; unclassified, n=989) compared with 92 870 comparators from the general population matched for sex, age, birth year, and county. Main outcome measures Any cancer and cancer types according to the Swedish Cancer Register. Results During follow-up through adulthood (median age at end of follow-up 27 years), 497 (3.3 per 1000 person years) people with childhood onset inflammatory bowel disease had first cancers, compared with 2256 (1.5 per 1000 person years) in the general population comparators (hazard ratio 2.2, 95% confidence interval 2.0 to 2.5). Hazard ratios for any cancer were 2.6 in ulcerative colitis (2.3 to 3.0) and 1.7 in Crohn’s disease (1.5 to 2.1). Patients also had an increased risk of cancer before their 18th birthday (2.7, 1.6 to 4.4; 20 cancers in 9405 patients, 0.6 per1000 person years). Gastrointestinal cancers had the highest relative risks, with a hazard ratio of 18.0 (14.4 to 22.7) corresponding to 202 cancers in patients with inflammatory bowel disease. The increased risk of cancer (before 25th birthday) was similar over time (1964-1989: 1.6, 1.0 to 2.4; 1990-2001: 2.3, 1.5 to 3.3); 2002-06: 2.9, 1.9 to 4.2; 2007-14: 2.2, 1.1 to 4.2). Conclusion Childhood onset inflammatory bowel disease is associated with an increased risk of any cancer, especially gastrointestinal cancers, both in childhood and later in life. The higher risk of cancer has not fallen over time.

Ensemble Prediction of Time-to-Event Outcomes with Competing Risks: A Case-Study of Surgical Complications in Crohn's Disease

“…A detailed description of the sources of data and methods for defining variables is available in Olén et al . (), and descriptive statistics for our study population are given in the on‐line supplementary materials.…”

Assessing Drug Safety in Children — The Role of Real-World Data

“…For example, the Swedish Cancer Registry was able to track cancer outcomes over a 50-year period in patients who had been treated for inflammatory bowel disease in childhood. 5 …”

No association between urbanisation, neighbourhood deprivation and IBD: a population-based study of 4 million individuals

“…Among these there were 3 177 828 siblings nested within 2 331 062 families. Within this cohort we identified individuals with IBD, defined as having ≥2 relevant International Classification of Diseases codes in the Swedish National Patient Register, as earlier described 4. Data from the Swedish Agency for Economic and Regional Growth were used to construct a rural index.…”